Clinical trials
29 active studies led by Shanghai JMT-Bio Inc., of 42 in all
Source: ClinicalTrials.gov, Studies with Shanghai JMT-Bio Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 3Markets in public records
- 0Regions & countries
- 29Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Shanghai JMT-Bio Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on Shanghai JMT-Bio Inc.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on ClinicalTrials.gov (opens in a new tab)
Trials over time
Studies Shanghai JMT-Bio Inc. leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Shanghai JMT-Bio Inc. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show Shanghai JMT-Bio Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets Shanghai JMT-Bio Inc. is in.
From our blog
Stories on the topics Shanghai JMT-Bio Inc. works in.
Bone and Joint Health: Supplements for an Ageing Population
1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence…
Read
Eye Health Supplements: Screens, Ageing and Vision
2.2 billion people have a vision impairment. One supplement formula has strong trial evidence, but only for a…
Read
Herbal Supplements: Quality, Safety and Trust
170 of 194 WHO member states report use of traditional medicine. Herbal products are popular, but quality and…
Read